HOME >> BIOLOGY >> NEWS
Crystal structure enables tailoring of pharmaceuticals against asthma

Researchers at Karolinska Institutet in Sweden have managed to elucidate the crystal structure of a human membrane protein LTC4 synthase which has a major influence on the development of asthma. LTC4 synthase is extremely difficult to analyze, and previously only low resolution information has been available on two membrane protein structures from human. The scientists now believe that their work will enable the development of new and better therapeutics against inflammations in the pulmonary tract.

Asthma attacks are caused by an acute inflammatory reaction in the airways, a reaction that is largely due to actions of LTC4 synthase. For this reason asthma medicines often aim at blocking the downstream effects of LTC4 synthase. However, there is a need for new pharmaceutical alternatives, since not all patients respond to the existing medicines.

Scientists at the Department of Medical Biochemistry and Biophysics have now, with the help of the two EU networks EICOSANOX and E-Mep, elucidated the three dimensional structure of the LTC4 synthase at 2.0 resolution (1 = 1 ngstrm = 10-10 m = 0,000 000 000 1 m). It is clear from the structure that the protein has three identical subunits, each of them consisting of four spiral structures that span the nuclear membrane. Also the exact position and characteristics of the active sites, where activating or blocking molecules can bind, have been identified. With this knowledge it is now possible to tailor new molecules that can block the LTC4 synthase.

The new results are also very important as they can lead the way for the development of new and more effective therapeutics against other diseases. Some 40 % of the proteins of interest for pharmaceutical developments are membrane proteins. Until now detailed structural information on these proteins has been absent, and therefore it has been difficult to fully understand their function. The present study is likely to lead the way for the deter
'"/>

Contact: Professor Pr Nordlund
Par.Nordlund@ki.se
46-070-433-6688
Karolinska Institutet
16-Jul-2007


Page: 1 2

Related biology news :

1. Crystal sponges excel at sopping up CO2
2. Scientists discover new way to study nanostructures
3. How to structure a complex body plan
4. HWI researchers determine structure of protein from pathogen associated with CF and TB
5. In search of the biological significance of modular structures in protein networks
6. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
7. Decoding protein structures helps illuminate cause of diabetes
8. Automatic identification of proteins critical features from the structure
9. ATR checkpoint-activating DNA structure
10. Scientists reveal structure of gateways to gene control
11. Protein structures for the entire yeast proteome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... CONSHOHOCKEN, Pa. (PRWEB) , ... May 21, 2019 , ... ... trial randomization and drug supply chain management, has been named one of Inc. Magazine’s ... , The full list , now featured on Inc.com and hitting the newsstands ...
(Date:5/21/2019)... ... May 21, 2019 , ... At their May 16 ... Tissue Engineered Medical Products (TEMPs) of the American Society for Testing and Materials ... Gaining this approval was the next step in the company’s plan to establish ...
(Date:5/14/2019)... (PRWEB) , ... May 13, 2019 , ... ... Tuesday, June 4th, at a very special Pre-EWMA 2019 event at Gothenburg’s Universeum ... the latest Trends, Opportunities and Innovations in Advanced Wound Care. , SmartTRAK’s Advanced ...
Breaking Biology News(10 mins):
(Date:4/16/2019)... ... April 16, 2019 , ... ... their project partner, the U.S. Army Center for Environmental Health Research (USACEHR), with ... Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the Frederick Innovative ...
(Date:4/15/2019)... ... 15, 2019 , ... Sirrus, Inc., a developer of novel ... expansion to increase production of methylene malonate monomers and oligomers. , The expanded ... full-scale production facility, which is scheduled to break ground in 2019. “The expanded ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... have locked into multiple agreements to help companies advance their innovations to ... industry, ranging from synthetic biology companies that are gene editing therapeutic cells ...
(Date:4/9/2019)... , ... April 09, 2019 , ... ... focused on increasing the capacity of life sciences organizations to accelerate innovation and ... Assurance platform in the past 12 months. , USDM’s Cloud Assurance ...
Breaking Biology Technology:
Cached News: